Evidence map›Paper›PMID 22588898›Full record

ArticleGenome research2012

Chimeras taking shape: potential functions of proteins encoded by chimeric RNA transcripts.

Milana Frenkel-Morgenstern, Vincent Lacroix, Iakes Ezkurdia, Yishai Levin, Alexandra Gabashvili, Jaime Prilusky, Angela Del Pozo, Michael Tress, Rory Johnson, Roderic Guigo and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Genome research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 137 citations in OpenAlex.

  1. Novel Perspectives onEpigenomes · 2026
    Article
  2. Review
  3. Identification of Cross-Strand Chimeric RNAs with cscMap.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  4. Article
  5. Promoter Specificity and Transcription Levels ModulateInternational journal of molecular sciences · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Pattern recognition in the landscape of seemingly random chimeric transcripts.Computational and structural biotechnology journal · 2023
    Article
  11. Review
  12. Novel read-through fusion transcript Bcl2l2-Pabpn1 in glioblastoma cells.Journal of cellular and molecular medicine · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 4 countries.

Milana Frenkel-MorgensternStructural Biology and BioComputing Program, Spanish National Cancer Research Centre, Madrid, Spain;
Vincent Lacroix
Iakes Ezkurdia
Yishai Levin
Alexandra Gabashvili
Jaime Prilusky
Angela Del Pozo
Michael Tress
Rory Johnson
Roderic Guigo
Alfonso Valencia
Spanish National Cancer Research Centre · ESWeizmann Institute of Science · ILCentre for Genomic Regulation · ESUniversité Claude Bernard Lyon 1 · FR

Funding

Comprehensive Characterization and Classification of the Human TranscriptomeU54HG004557 · NHGRI · COLD SPRING HARBOR LABORATORY · PI GINGERAS, THOMAS RAYMOND · 2007 to 2011
$14.5M
Integrated human genome annotation: generation of a reference gene setU54HG004555 · NHGRI · SANGER INSTITUTE · PI HUBBARD, TIMOTHY JOHN · 2007 to 2012
$11.2M
NHGRI NIH HHS U54 HG004555NHGRI NIH HHS U54 HG004557
6 · The paper itself

Abstract

Chimeric RNAs comprise exons from two or more different genes and have the potential to encode novel proteins that alter cellular phenotypes. To date, numerous putative chimeric transcripts have been identified among the ESTs isolated from several organisms and using high throughput RNA sequencing. The few corresponding protein products that have been characterized mostly result from chromosomal translocations and are associated with cancer. Here, we systematically establish that some of the putative chimeric transcripts are genuinely expressed in human cells. Using high throughput RNA sequencing, mass spectrometry experimental data, and functional annotation, we studied 7424 putative human chimeric RNAs. We confirmed the expression of 175 chimeric RNAs in 16 human tissues, with an abundance varying from 0.06 to 17 RPKM (Reads Per Kilobase per Million mapped reads). We show that these chimeric RNAs are significantly more tissue-specific than non-chimeric transcripts. Moreover, we present evidence that chimeras tend to incorporate highly expressed genes. Despite the low expression level of most chimeric RNAs, we show that 12 novel chimeras are translated into proteins detectable in multiple shotgun mass spectrometry experiments. Furthermore, we confirm the expression of three novel chimeric proteins using targeted mass spectrometry. Finally, based on our functional annotation of exon organization and preserved domains, we discuss the potential features of chimeric proteins with illustrative examples and suggest that chimeras significantly exploit signal peptides and transmembrane domains, which can alter the cellular localization of cognate proteins. Taken together, these findings establish that some chimeric RNAs are translated into potentially functional proteins in humans.

Indexed as

Genome, HumanProtein BiosynthesisAmino Acid SequenceCell MembraneDatabases, Nucleic AcidExonsGene Expression RegulationHigh-Throughput Nucleotide SequencingHumansMass SpectrometryMolecular Sequence AnnotationMolecular Sequence DataMutant Chimeric ProteinsOrgan SpecificityProtein Sorting SignalsProtein Structure, SecondaryMutant Chimeric ProteinsProtein Sorting SignalsRNA, Messenger

Identifiers

PMID22588898
PMCPMC3396365
OpenAlexW2142386866

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.